Three reasons 1) Too many drugs being trialed and not enough patient meeting criteria. Everyone going after severe critical 2) Politics. I’m republican. One could be pressure to push news back until right before election to get momentum for Trump or two Democrat hold up to impact stock market and economy. 3) HGEN is trying to make a perfect study and possibly avoiding patients with dexamethsone. The one of the 12 that remained in hospital and vented had dexamethsone (the only negative one)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.